Functional prognosis prediction for the effect of botulinum toxin therapy on upper limb in post-stroke patients using hierarchical cluster analysis

Functional prognosis prediction for the effect of botulinum toxin therapy on upper limb in post-stroke patients using hierarchical cluster analysis - The effect of botulinum toxin therapy on upper limb in post-stroke patients using hierarchical cluster analysis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000042313

Enrollment

140

Registered

2020-11-01

Start date

2014-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post stroke patients

Interventions

botulinum toxin A + intensive rehabilitation usual rehabilitation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) patients with hemiplegia following a stroke that involved upper limb spasticity (with a Modified Ashworth Scale score equal to or greater than 1; (2) >6 months since the onset of stroke; (3) no prior BoNT- A injections; (4) no contraindications for BoNT-A injections.

Exclusion criteria

Exclusion criteria: (1) taking anti-spasticity medications, and (2) a history of BoNT-A injections.

Design outcomes

Primary

Measure	Time frame
The Fugl-Meyer Assessment (FMA)	—

Countries

Japan

Contacts

Public ContactTakatoshi Hara

The Jikei University School of Medicine Department of Rehabilitaion Medicine

t_hara1019@jikei.ac.jp+81-3-3433-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026